JAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLC

JAZZ PHARMACEUTICALS PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.41 B‬EUR
8.80EUR
‪541.06 M‬EUR
‪3.93 B‬EUR
‪58.83 M‬
Beta (1Y)
0.79
Employees (FY)
‪2.8 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪1.40 M‬EUR
Net income / Employee (1Y)
‪193.24 K‬EUR

About Jazz Pharmaceuticals plc


CEO
Bruce C. Cozadd
Headquarters
Dublin
Founded
2005
ISIN
IE00B4Q5ZN47
FIGI
BBG01TNVTQL9
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1JAZZ.

Frequently Asked Questions


The current price of 1JAZZ is 103.05 EUR — it has decreased by −2.74% in the past 24 hours. Watch JAZZ PHARMACEUTICALS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange JAZZ PHARMACEUTICALS PLC stocks are traded under the ticker 1JAZZ.
1JAZZ stock has risen by 2.33% compared to the previous week, the month change is a 9.33% rise, over the last year JAZZ PHARMACEUTICALS PLC has showed a 9.33% increase.
We've gathered analysts' opinions on JAZZ PHARMACEUTICALS PLC future price: according to them, 1JAZZ price has a max estimate of 202.01 EUR and a min estimate of 109.79 EUR. Watch 1JAZZ chart and read a more detailed JAZZ PHARMACEUTICALS PLC stock forecast: see what analysts think of JAZZ PHARMACEUTICALS PLC and suggest that you do with its stocks.
1JAZZ reached its all-time high on May 2, 2025 with the price of 105.25 EUR, and its all-time low was 94.25 EUR and was reached on Apr 25, 2025. View more price dynamics on 1JAZZ chart.
See other stocks reaching their highest and lowest prices.
1JAZZ stock is 2.81% volatile and has beta coefficient of 0.79. Track JAZZ PHARMACEUTICALS PLC stock price on the chart and check out the list of the most volatile stocks — is JAZZ PHARMACEUTICALS PLC there?
Today JAZZ PHARMACEUTICALS PLC has the market capitalization of ‪6.41 B‬, it has increased by 11.11% over the last week.
Yes, you can track JAZZ PHARMACEUTICALS PLC financials in yearly and quarterly reports right on TradingView.
JAZZ PHARMACEUTICALS PLC is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1JAZZ earnings for the last quarter are 1.55 EUR per share, whereas the estimation was 4.31 EUR resulting in a −63.93% surprise. The estimated earnings for the next quarter are 5.10 EUR per share. See more details about JAZZ PHARMACEUTICALS PLC earnings.
JAZZ PHARMACEUTICALS PLC revenue for the last quarter amounts to ‪829.91 M‬ EUR, despite the estimated figure of ‪909.34 M‬ EUR. In the next quarter, revenue is expected to reach ‪936.43 M‬ EUR.
1JAZZ net income for the last quarter is ‪184.61 M‬ EUR, while the quarter before that showed ‪193.15 M‬ EUR of net income which accounts for −4.42% change. Track more JAZZ PHARMACEUTICALS PLC financial stats to get the full picture.
No, 1JAZZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has ‪2.8 K‬ employees. See our rating of the largest employees — is JAZZ PHARMACEUTICALS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAZZ PHARMACEUTICALS PLC EBITDA is ‪1.34 B‬ EUR, and current EBITDA margin is 34.08%. See more stats in JAZZ PHARMACEUTICALS PLC financial statements.
Like other stocks, 1JAZZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAZZ PHARMACEUTICALS PLC stock right from TradingView charts — choose your broker and connect to your account.